China National Accord Medicines Corp Ltd Class A 000028
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- CNY 34.81
- Day Range
- CNY 34.57–35.77
- 52-Week Range
- CNY 26.06–52.55
- Bid/Ask
- CNY 35.12 / CNY 35.13
- Market Cap
- CNY 19.55 Bil
- Volume/Avg
- 4.3 Mil / 5.3 Mil
Key Statistics
- Price/Earnings (Normalized)
- 12.83
- Price/Sales
- 0.26
- Dividend Yield (Trailing)
- 2.28%
- Dividend Yield (Forward)
- 2.28%
- Total Yield
- 2.28%
Company Profile
China National Accord Medicines Corp Ltd develops and manufactures pharmaceuticals in China. The company engaged in the wholesale of Chinese patent drugs, traditional Chinese medicines, chemical medicine preparations, antibiotics, biochemical drugs and cerebrovascular system drugs. It operates through the following segments: The Head office segment engages in investing and managing the business; The Pharmaceutical Distribution segment engages in the distribution of medicine and pharmaceutical products to customers, including hospitals, other distributors, retail drug stores, and clinics, and Retail pharmacy segment, which is managing the operation of Guoda Pharmacy. It generates maximum revenue from the Pharmaceutical Distribution segment.
- Sector
- Healthcare
- Industry
- Medical Distribution
- Stock Style Box
- Mid Value
- Total Number of Employees
- 39,449
- Website
- http://www.szaccord.com.cn
Comparables
Valuation
|
Metric
|
000028
|
300391
|
600993
|
|---|---|---|---|
Price/Earnings (Normalized) | 12.83 | — | 29.67 |
Price/Book Value | 1.10 | 2.07 | 3.07 |
Price/Sales | 0.26 | 1.17 | 3.68 |
Price/Cash Flow | 9.35 | 22.98 | 15.91 |
Price/Earnings
000028
300391
600993
Financial Strength
|
Metric
|
000028
|
300391
|
600993
|
|---|---|---|---|
Quick Ratio | — | 0.95 | 6.26 |
Current Ratio | — | 1.10 | 7.29 |
Interest Coverage | — | −1.40 | 32.00 |
Quick Ratio
000028
300391
600993
Profitability
|
Metric
|
000028
|
300391
|
600993
|
|---|---|---|---|
Return on Assets (Normalized) | 3.13% | −7.93% | 8.13% |
Return on Equity (Normalized) | 9.09% | −37.45% | 11.43% |
Return on Invested Capital (Normalized) | 6.32% | −9.16% | 8.64% |
Return on Assets
000028
300391
600993
Medical Distribution Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
MCK
| McKesson Corp | Fmktlklt | Kjrftyz | $69.8 Bil | |
COR
| Cencora Inc | Lbdshzvj | Jrbrtz | $45.7 Bil | |
CAH
| Cardinal Health Inc | Fqvtpyjn | Jjkrqj | $24.9 Bil | |
SHPMF
| Shanghai Pharmaceuticals Holding Co Ltd Class H | — | Cqymk | $8.2 Bil | |
SHPMY
| Shanghai Pharmaceuticals Holding Co Ltd ADR repr Class H | — | Mptzds | $8.2 Bil | |
SHTDF
| Sinopharm Group Co Ltd | — | Zxnyxv | $7.9 Bil | |
SHTDY
| Sinopharm Group Co Ltd ADR | — | Cyknk | $7.9 Bil | |
AMFPF
| Amplifon SpA Az nom Post Frazionamento | — | Jbzgtgj | $7.6 Bil | |
MAHLY
| Medipal Holdings Corp ADR | — | Wgzb | $3.3 Bil | |
MEPDF
| Medipal Holdings Corp | — | Znl | $3.3 Bil |